SlideShare una empresa de Scribd logo
1 de 37
Injecting Drug Use, HIV/AIDS Epidemic and Harm Reduction Strategies Fabio Mesquita, MD, PhD Harm Reduction Adviser IHPCP - Indonesia Pertemuan Nasional HIV & AIDS Ke – 3 Surabaya – 2007
TWO MAJOR EPIDEMICS AIDS DRUGS
Drug Epidemic AIDS Epidemic
WORLD DRUG REPORT, UNODC 2005 ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Guiyang Kunming Mandalay Yangon Chiang Mai Bangkok Hanoi Vientian e Phnom Penh Ho Chi Minh City Songkhla MYANMAR LAOS CAMBODIA THAILAND VIETNAM CHINA Hong Kong MAJOR HEROIN TRAFFICKING ROUTES IN SE Asia Source: UNODC Regional Centre for East Asia and the Pacific Courtesy BBC   World
HIV/AIDS  Hepatitis B, C and D Overdoses Hepatic chronic diseases Co-Morbidity with Mental Health Addiction Abscesses  Endocarditic  Syphilis, Malaria, HTLV, etc Tuberculosis/Other Respiratory diseases Car accident Occupational Accidents  Violent deaths HEALTH CONSEQUENCES
Adults and children estimated to be living with HIV as of end 2005 Total: 40.3 (36.7 – 45.3) million  Western & Central Europe 720 000 [570 000 – 890 000] North Africa & Middle East 510 000 [230 000 – 1.4 million] Sub-Saharan Africa 25.8 million [23.8 – 28.9 million] Eastern Europe  & Central Asia 1.6 million  [990 000 – 2.3 million] South & South-East Asia 7.4 million [4.5 – 11.0 million] Oceania 74 000 [45 000 – 120 000] North America 1.2 million [650 000 – 1.8 million] Caribbean 300 000 [200 000 – 510 000] Latin America 1.8 million [1.4 – 2.4 million] East Asia 870 000 [440 000 – 1.4 million]
Most countries have IDU ignited HIV Non IDU initiated IDU initiated
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Brazil: the epidemiological picture ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CONDONS AVAILABLE FOR FREE  DISTRIBUTION 800 MILLION FOR 2006 1 BILLION FOR 2007 PLUS REGULAR MARKET AND SOCIAL MARKET (DKT)
TEST AND COUNSELING  FIRST VCT OPEN IN 1989 TOTAL POPULATION EVER TESTED  28,1%  - AUGUST 2004
BRAZILIAN ARV ACCESS PROGRAM: MAJOR ASPECTS  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
0 20000 40000 60000 80000 100000 120000 140000 160000 180000 jan/97 abr/97 jul/97 out/97 jan/98 abr/98 jul/98 out/98 jan/99 abr/99 jul/99 out/99 jan/00 abr/00 jul/00 out/00 jan/01 abr/01 jul/01 out/01 jan/02 abr/02 jul/02 out/02 jan/03 abr/03 jul/03 out/03 jan/04 abr/04 jul/04 out/04 jan/05 abr/05 jul/05 out/05 170.000 * Dados preliminares Projected Number of patients receiving ARV therapy.  Brazil, 1997 – 2005
* Brazilian local production ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ITRN and ITRNt ,[object Object],IP FUSION INHIBITOR ITRNN Antiretroviral drugs distributed through Brazilian public health system, according to therapeutic category. Brazil, 2005
ARV availability in low and middle income countries, according to geographical region. June, 2005* Source: “Progress on Global Access to HIV Antiretroviral Therapy, June 2005 update, World Health Organization  Region Number of people receiving ARVs Estimated need Coverage Sub-Saharan Africa 500,000 4,700,000 11% East, South and South-East Asia 155,000 1,100,000 14% North Africa and  Middle East 4,000 75,000 5% Eastern Europe and  Central Asia Central 20,000 160,000 13% Latin America and the Caribbean 290,000 465,000 62% Total 970,000 6,500,000 15% (Average) *Adults only, average figures
AIDS Hospital Admissions in Public Health System in Post HAART Era. Brazil (1996-2001) Source: MOH, 2002
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
AIDS incidence and mortality rates (by 100,000 inhabitants) Brazil, 1985-2003 Sources:  Incidence - PN STD-AIDS/SVS/MH.  Mortality – SIM/DASIS/SVS/MH 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 0 5 10 15 20 25 Mortality Incidence
Distribution of PCP, Toxoplasmosis and Tuberculosis in Reported AIDS Cases to MOH (Brazil, 1981-2001) Source: MOH, 2002 HAART
Estimate of HIV Infected Individuals  (among 15 a 49 years old) by year 2000 Word Bank Projection (1992) Brazilian MOH Estimate (2000) 0 200 400 600 800 1000 1200 1400 Thousands 1,200,000 600,000 MOH, 2002  50%
Dados de Casos de AIDS no Brasil  Gráfico 1 – Casos de aids segundo ano de diagnóstico. Brasil, 1980-2003.                                                                                                                                                               Fonte: MS/SVS/PN DST e Aids/SINAN.  
INDONESIAN RESPONSE FOR HIV/AIDS  CRISIS AMONG AND FROM IDUS First AIDS case in Indonesia: 1987 First case in IDU: 1995 First Harm Reduction Project: 1999 Ongoing: NEP. Methadone, CST for IDUs
Grafik 1:  Jumlah  Kasus  AIDS  di  Indonesia  10  Tahun  Terakhir  Berdasarkan Tahun Pelaporan  sd  31 Maret 2006 ----------------------------------------------------------------------------------------------------------- Figure 1 : Number of AIDS Cases in Indonesia in Last 10 Years up to March 31, 2006
Risk Factors Indonesian Epidemic
Harm Reduction Definition ,[object Object]
HIV PREVENTION AND CARE FOR IDUs After 25 years of the HIV/AIDS we’ve learned how  to confront the epidemic among and from injecting drug users
[object Object],[object Object],[object Object],[object Object],HIV PREVENTION AND CARE FOR IDUs IN INDONESIA
[object Object],[object Object],[object Object],How to deliver services
Evolution of Indonesian Response - NSP
[object Object],[object Object],[object Object],Evolution of Methadone services
[object Object],[object Object],[object Object],[object Object],[object Object],Evolution of CST for IDUs
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BIG CHALLENGES

Más contenido relacionado

La actualidad más candente

A basic understanding o f H I V surveillance
A basic understanding o f H I V surveillanceA basic understanding o f H I V surveillance
A basic understanding o f H I V surveillanceDr.RAJEEV KASHYAP
 
National cancer control programme
National cancer control programmeNational cancer control programme
National cancer control programmesrabana bhagabaty
 
National AIDS Control Programme NACP
National AIDS Control Programme NACPNational AIDS Control Programme NACP
National AIDS Control Programme NACPHarsh Rastogi
 
Respina lecture tb philippine experience 1 jenifer ann mendoza
Respina lecture tb philippine experience 1 jenifer ann mendozaRespina lecture tb philippine experience 1 jenifer ann mendoza
Respina lecture tb philippine experience 1 jenifer ann mendozapoe_ku
 
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIANATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIABharat Masal
 
Game Changer by Dr Shaari Ngadiman
Game Changer by Dr Shaari NgadimanGame Changer by Dr Shaari Ngadiman
Game Changer by Dr Shaari NgadimanDr. Rubz
 
Hiv general (30 august 2007)
Hiv general (30 august 2007)Hiv general (30 august 2007)
Hiv general (30 august 2007)Mohamed Rafique
 
National aids control programme
National  aids control programmeNational  aids control programme
National aids control programmeDr.Jatheesh Mohan
 
NATIONAL VIRAL HEPATITIS CONTROL PROGRAM
NATIONAL VIRAL HEPATITIS CONTROL PROGRAMNATIONAL VIRAL HEPATITIS CONTROL PROGRAM
NATIONAL VIRAL HEPATITIS CONTROL PROGRAMDrPANKAJCHAUDHARY1
 
Revised national tuberculosis control programme
Revised national tuberculosis control programmeRevised national tuberculosis control programme
Revised national tuberculosis control programmeRavi Rohilla
 
National aids control programme
National aids control programmeNational aids control programme
National aids control programmeImmanuel Joshua
 
Cancer control program
Cancer control programCancer control program
Cancer control programAbino David
 
National cancer control programme
National cancer control programmeNational cancer control programme
National cancer control programmeanjalatchi
 
Hiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi SarkarHiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi Sarkarmrikara185
 
Recent updates in TB programme
Recent updates in TB programmeRecent updates in TB programme
Recent updates in TB programmeAvantikaGupta33
 
National AIDS control program
National AIDS control programNational AIDS control program
National AIDS control programmigom doley
 

La actualidad más candente (20)

Cancer registry
Cancer registryCancer registry
Cancer registry
 
A basic understanding o f H I V surveillance
A basic understanding o f H I V surveillanceA basic understanding o f H I V surveillance
A basic understanding o f H I V surveillance
 
National cancer control programme
National cancer control programmeNational cancer control programme
National cancer control programme
 
National AIDS Control Programme NACP
National AIDS Control Programme NACPNational AIDS Control Programme NACP
National AIDS Control Programme NACP
 
RNTCP
RNTCPRNTCP
RNTCP
 
Respina lecture tb philippine experience 1 jenifer ann mendoza
Respina lecture tb philippine experience 1 jenifer ann mendozaRespina lecture tb philippine experience 1 jenifer ann mendoza
Respina lecture tb philippine experience 1 jenifer ann mendoza
 
National cancer control programme
National cancer control programmeNational cancer control programme
National cancer control programme
 
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIANATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
 
National response to hiv
National response to hivNational response to hiv
National response to hiv
 
Game Changer by Dr Shaari Ngadiman
Game Changer by Dr Shaari NgadimanGame Changer by Dr Shaari Ngadiman
Game Changer by Dr Shaari Ngadiman
 
Hiv general (30 august 2007)
Hiv general (30 august 2007)Hiv general (30 august 2007)
Hiv general (30 august 2007)
 
National aids control programme
National  aids control programmeNational  aids control programme
National aids control programme
 
NATIONAL VIRAL HEPATITIS CONTROL PROGRAM
NATIONAL VIRAL HEPATITIS CONTROL PROGRAMNATIONAL VIRAL HEPATITIS CONTROL PROGRAM
NATIONAL VIRAL HEPATITIS CONTROL PROGRAM
 
Revised national tuberculosis control programme
Revised national tuberculosis control programmeRevised national tuberculosis control programme
Revised national tuberculosis control programme
 
National aids control programme
National aids control programmeNational aids control programme
National aids control programme
 
Cancer control program
Cancer control programCancer control program
Cancer control program
 
National cancer control programme
National cancer control programmeNational cancer control programme
National cancer control programme
 
Hiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi SarkarHiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi Sarkar
 
Recent updates in TB programme
Recent updates in TB programmeRecent updates in TB programme
Recent updates in TB programme
 
National AIDS control program
National AIDS control programNational AIDS control program
National AIDS control program
 

Destacado

Destacado (7)

Demography
DemographyDemography
Demography
 
zidovudine hplc method
zidovudine hplc method zidovudine hplc method
zidovudine hplc method
 
82838902 case-study-on-dengue
82838902 case-study-on-dengue82838902 case-study-on-dengue
82838902 case-study-on-dengue
 
Scientific Sessions 2015: HIV estimations and projections 2015
Scientific Sessions 2015: HIV estimations and projections 2015Scientific Sessions 2015: HIV estimations and projections 2015
Scientific Sessions 2015: HIV estimations and projections 2015
 
Quest testimony
Quest testimonyQuest testimony
Quest testimony
 
MACROECONOMIC (roles of government)
MACROECONOMIC (roles of government)MACROECONOMIC (roles of government)
MACROECONOMIC (roles of government)
 
Hype vs. Reality: The AI Explainer
Hype vs. Reality: The AI ExplainerHype vs. Reality: The AI Explainer
Hype vs. Reality: The AI Explainer
 

Similar a Injecting Drug Use, HIV/AIDS Epidemic and Harm Reduction Strategies

01 Aynalem_Adugna_HIV_AIDS_in_Ethiopia.pdf
01 Aynalem_Adugna_HIV_AIDS_in_Ethiopia.pdf01 Aynalem_Adugna_HIV_AIDS_in_Ethiopia.pdf
01 Aynalem_Adugna_HIV_AIDS_in_Ethiopia.pdfAMANUELMELAKU5
 
nationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdfnationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdfssuserd6cc4b
 
Gender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girlsGender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girlsSumaiya Akter Snigdha
 
Public injecting, harm reduction services
Public injecting, harm reduction servicesPublic injecting, harm reduction services
Public injecting, harm reduction servicesJozsef Racz
 
Dec2010 1final ll
Dec2010 1final llDec2010 1final ll
Dec2010 1final llLut Lynen
 
Overview of HIVAIDS in Ethiopia.ppt
Overview of HIVAIDS in Ethiopia.pptOverview of HIVAIDS in Ethiopia.ppt
Overview of HIVAIDS in Ethiopia.pptHaramaya University
 
07 Trend in ethiopia for last 26 years.pdf
07 Trend in ethiopia for last 26 years.pdf07 Trend in ethiopia for last 26 years.pdf
07 Trend in ethiopia for last 26 years.pdfAMANUELMELAKU5
 
Fast track, incestment spproach and transition funding to end aids epidemic b...
Fast track, incestment spproach and transition funding to end aids epidemic b...Fast track, incestment spproach and transition funding to end aids epidemic b...
Fast track, incestment spproach and transition funding to end aids epidemic b...PinHealth
 
Overview of the national Methadone Maintenance Treatment (MMT) program in Vie...
Overview of the national Methadone Maintenance Treatment (MMT) program in Vie...Overview of the national Methadone Maintenance Treatment (MMT) program in Vie...
Overview of the national Methadone Maintenance Treatment (MMT) program in Vie...Geraldine Cazorla
 
OVERVIEW OF HIV/AIDS EPIDEMIC IN ASIA
OVERVIEW OF HIV/AIDS EPIDEMIC IN ASIAOVERVIEW OF HIV/AIDS EPIDEMIC IN ASIA
OVERVIEW OF HIV/AIDS EPIDEMIC IN ASIAGayatri Khanal
 
Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"HopkinsCFAR
 
National Health Policy (Nepal)
National Health Policy (Nepal)National Health Policy (Nepal)
National Health Policy (Nepal)SwikritiKoirala3
 

Similar a Injecting Drug Use, HIV/AIDS Epidemic and Harm Reduction Strategies (20)

01 Aynalem_Adugna_HIV_AIDS_in_Ethiopia.pdf
01 Aynalem_Adugna_HIV_AIDS_in_Ethiopia.pdf01 Aynalem_Adugna_HIV_AIDS_in_Ethiopia.pdf
01 Aynalem_Adugna_HIV_AIDS_in_Ethiopia.pdf
 
nationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdfnationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdf
 
Gender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girlsGender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girls
 
Public injecting, harm reduction services
Public injecting, harm reduction servicesPublic injecting, harm reduction services
Public injecting, harm reduction services
 
Dec2010 1final ll
Dec2010 1final llDec2010 1final ll
Dec2010 1final ll
 
Overview of HIVAIDS in Ethiopia.ppt
Overview of HIVAIDS in Ethiopia.pptOverview of HIVAIDS in Ethiopia.ppt
Overview of HIVAIDS in Ethiopia.ppt
 
07 Trend in ethiopia for last 26 years.pdf
07 Trend in ethiopia for last 26 years.pdf07 Trend in ethiopia for last 26 years.pdf
07 Trend in ethiopia for last 26 years.pdf
 
Fast track, incestment spproach and transition funding to end aids epidemic b...
Fast track, incestment spproach and transition funding to end aids epidemic b...Fast track, incestment spproach and transition funding to end aids epidemic b...
Fast track, incestment spproach and transition funding to end aids epidemic b...
 
Demographic profile of aids pt.
Demographic profile of aids pt.Demographic profile of aids pt.
Demographic profile of aids pt.
 
Aids patients demographic profile
Aids patients demographic profileAids patients demographic profile
Aids patients demographic profile
 
karan singh
karan singhkaran singh
karan singh
 
Overview of the national Methadone Maintenance Treatment (MMT) program in Vie...
Overview of the national Methadone Maintenance Treatment (MMT) program in Vie...Overview of the national Methadone Maintenance Treatment (MMT) program in Vie...
Overview of the national Methadone Maintenance Treatment (MMT) program in Vie...
 
Austin Aging Research
Austin Aging Research Austin Aging Research
Austin Aging Research
 
OVERVIEW OF HIV/AIDS EPIDEMIC IN ASIA
OVERVIEW OF HIV/AIDS EPIDEMIC IN ASIAOVERVIEW OF HIV/AIDS EPIDEMIC IN ASIA
OVERVIEW OF HIV/AIDS EPIDEMIC IN ASIA
 
Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"Chris Beyrer: "State of the Science: Key populations"
Chris Beyrer: "State of the Science: Key populations"
 
Dr Pramod Dr Sudipta
Dr Pramod Dr SudiptaDr Pramod Dr Sudipta
Dr Pramod Dr Sudipta
 
NACP
NACPNACP
NACP
 
National Health Policy (Nepal)
National Health Policy (Nepal)National Health Policy (Nepal)
National Health Policy (Nepal)
 
GKA deel 2 college 13
GKA deel 2 college 13GKA deel 2 college 13
GKA deel 2 college 13
 
Wiki assignement
Wiki assignementWiki assignement
Wiki assignement
 

Más de Sketchpowder, Inc.

Ilustrasi Kerangka Ekonomi Napza
Ilustrasi Kerangka Ekonomi NapzaIlustrasi Kerangka Ekonomi Napza
Ilustrasi Kerangka Ekonomi NapzaSketchpowder, Inc.
 
Community Action on Harm Reduction: A Learning Documentation
Community Action on Harm Reduction: A Learning DocumentationCommunity Action on Harm Reduction: A Learning Documentation
Community Action on Harm Reduction: A Learning DocumentationSketchpowder, Inc.
 
Legenda Pohon Ganja - LGN, 2011
Legenda Pohon Ganja - LGN, 2011Legenda Pohon Ganja - LGN, 2011
Legenda Pohon Ganja - LGN, 2011Sketchpowder, Inc.
 
Refleksi transformatif war on drugs cover preview
Refleksi transformatif war on drugs   cover previewRefleksi transformatif war on drugs   cover preview
Refleksi transformatif war on drugs cover previewSketchpowder, Inc.
 
Intuisi, Inc. - Company Profile
Intuisi, Inc. - Company ProfileIntuisi, Inc. - Company Profile
Intuisi, Inc. - Company ProfileSketchpowder, Inc.
 
Layanan Alat Suntik Steril di Lapas dan Rutan Indonesia: Sebuah Penjajakan
Layanan Alat Suntik Steril di Lapas dan Rutan Indonesia: Sebuah PenjajakanLayanan Alat Suntik Steril di Lapas dan Rutan Indonesia: Sebuah Penjajakan
Layanan Alat Suntik Steril di Lapas dan Rutan Indonesia: Sebuah PenjajakanSketchpowder, Inc.
 
Hunian yang Melebihi Kapasitas dan Kondisi Kesehatan di Lapas/Rutan Indonesia
Hunian yang Melebihi Kapasitas dan Kondisi Kesehatan di Lapas/Rutan IndonesiaHunian yang Melebihi Kapasitas dan Kondisi Kesehatan di Lapas/Rutan Indonesia
Hunian yang Melebihi Kapasitas dan Kondisi Kesehatan di Lapas/Rutan IndonesiaSketchpowder, Inc.
 
Mengurangi mudarat konsumsi napza di kalangan remaja dan komunitasnya
Mengurangi mudarat konsumsi napza di kalangan remaja dan komunitasnyaMengurangi mudarat konsumsi napza di kalangan remaja dan komunitasnya
Mengurangi mudarat konsumsi napza di kalangan remaja dan komunitasnyaSketchpowder, Inc.
 
Rencana Aksi Nasional Penanggulangan AIDS dan Narkoba di Jajaran Pemasyarakat...
Rencana Aksi Nasional Penanggulangan AIDS dan Narkoba di Jajaran Pemasyarakat...Rencana Aksi Nasional Penanggulangan AIDS dan Narkoba di Jajaran Pemasyarakat...
Rencana Aksi Nasional Penanggulangan AIDS dan Narkoba di Jajaran Pemasyarakat...Sketchpowder, Inc.
 
Panduan Diskusi Kelompok Pengguna Napza Suntik
Panduan Diskusi Kelompok Pengguna Napza SuntikPanduan Diskusi Kelompok Pengguna Napza Suntik
Panduan Diskusi Kelompok Pengguna Napza SuntikSketchpowder, Inc.
 
Harm Reduction - Kebijakan dan Strategi Indonesia
Harm Reduction - Kebijakan dan Strategi IndonesiaHarm Reduction - Kebijakan dan Strategi Indonesia
Harm Reduction - Kebijakan dan Strategi IndonesiaSketchpowder, Inc.
 
Dokumentasi Pelanggaran HAM di Kelompok Pengguna Narkoba Suntik
Dokumentasi Pelanggaran HAM di Kelompok Pengguna Narkoba SuntikDokumentasi Pelanggaran HAM di Kelompok Pengguna Narkoba Suntik
Dokumentasi Pelanggaran HAM di Kelompok Pengguna Narkoba SuntikSketchpowder, Inc.
 
Laporan Pertemuan Nasional Pengurangan Dampak Buruk Narkoba Suntik 2008
Laporan Pertemuan Nasional Pengurangan Dampak Buruk Narkoba Suntik 2008Laporan Pertemuan Nasional Pengurangan Dampak Buruk Narkoba Suntik 2008
Laporan Pertemuan Nasional Pengurangan Dampak Buruk Narkoba Suntik 2008Sketchpowder, Inc.
 
Standar Biaya Umum Tahun Anggaran 2009
Standar Biaya Umum Tahun Anggaran 2009Standar Biaya Umum Tahun Anggaran 2009
Standar Biaya Umum Tahun Anggaran 2009Sketchpowder, Inc.
 
Protokol Opsional untuk Konvensi PBB Menentang Penyiksaan
Protokol Opsional  untuk Konvensi PBB Menentang  PenyiksaanProtokol Opsional  untuk Konvensi PBB Menentang  Penyiksaan
Protokol Opsional untuk Konvensi PBB Menentang PenyiksaanSketchpowder, Inc.
 
Pedoman PelaksanaanProgram Terapi Rumatan Metadon di Lembaga Pemasyarakatan d...
Pedoman PelaksanaanProgram Terapi Rumatan Metadon di Lembaga Pemasyarakatan d...Pedoman PelaksanaanProgram Terapi Rumatan Metadon di Lembaga Pemasyarakatan d...
Pedoman PelaksanaanProgram Terapi Rumatan Metadon di Lembaga Pemasyarakatan d...Sketchpowder, Inc.
 
PENGATURAN KHUSUS PENYALURAN DAN PENYERAHAN BUPRENORFIN
PENGATURAN KHUSUS PENYALURAN DAN PENYERAHAN BUPRENORFINPENGATURAN KHUSUS PENYALURAN DAN PENYERAHAN BUPRENORFIN
PENGATURAN KHUSUS PENYALURAN DAN PENYERAHAN BUPRENORFINSketchpowder, Inc.
 

Más de Sketchpowder, Inc. (20)

Ilustrasi Kerangka Ekonomi Napza
Ilustrasi Kerangka Ekonomi NapzaIlustrasi Kerangka Ekonomi Napza
Ilustrasi Kerangka Ekonomi Napza
 
Community Action on Harm Reduction: A Learning Documentation
Community Action on Harm Reduction: A Learning DocumentationCommunity Action on Harm Reduction: A Learning Documentation
Community Action on Harm Reduction: A Learning Documentation
 
Legenda Pohon Ganja - LGN, 2011
Legenda Pohon Ganja - LGN, 2011Legenda Pohon Ganja - LGN, 2011
Legenda Pohon Ganja - LGN, 2011
 
Refleksi transformatif war on drugs cover preview
Refleksi transformatif war on drugs   cover previewRefleksi transformatif war on drugs   cover preview
Refleksi transformatif war on drugs cover preview
 
Intuisi, Inc. - Company Profile
Intuisi, Inc. - Company ProfileIntuisi, Inc. - Company Profile
Intuisi, Inc. - Company Profile
 
Layanan Alat Suntik Steril di Lapas dan Rutan Indonesia: Sebuah Penjajakan
Layanan Alat Suntik Steril di Lapas dan Rutan Indonesia: Sebuah PenjajakanLayanan Alat Suntik Steril di Lapas dan Rutan Indonesia: Sebuah Penjajakan
Layanan Alat Suntik Steril di Lapas dan Rutan Indonesia: Sebuah Penjajakan
 
Perempuan di Lingkar Napza
Perempuan di Lingkar NapzaPerempuan di Lingkar Napza
Perempuan di Lingkar Napza
 
Hunian yang Melebihi Kapasitas dan Kondisi Kesehatan di Lapas/Rutan Indonesia
Hunian yang Melebihi Kapasitas dan Kondisi Kesehatan di Lapas/Rutan IndonesiaHunian yang Melebihi Kapasitas dan Kondisi Kesehatan di Lapas/Rutan Indonesia
Hunian yang Melebihi Kapasitas dan Kondisi Kesehatan di Lapas/Rutan Indonesia
 
Mengurangi mudarat konsumsi napza di kalangan remaja dan komunitasnya
Mengurangi mudarat konsumsi napza di kalangan remaja dan komunitasnyaMengurangi mudarat konsumsi napza di kalangan remaja dan komunitasnya
Mengurangi mudarat konsumsi napza di kalangan remaja dan komunitasnya
 
Rencana Aksi Nasional Penanggulangan AIDS dan Narkoba di Jajaran Pemasyarakat...
Rencana Aksi Nasional Penanggulangan AIDS dan Narkoba di Jajaran Pemasyarakat...Rencana Aksi Nasional Penanggulangan AIDS dan Narkoba di Jajaran Pemasyarakat...
Rencana Aksi Nasional Penanggulangan AIDS dan Narkoba di Jajaran Pemasyarakat...
 
Panduan Diskusi Kelompok Pengguna Napza Suntik
Panduan Diskusi Kelompok Pengguna Napza SuntikPanduan Diskusi Kelompok Pengguna Napza Suntik
Panduan Diskusi Kelompok Pengguna Napza Suntik
 
Harm Reduction - Kebijakan dan Strategi Indonesia
Harm Reduction - Kebijakan dan Strategi IndonesiaHarm Reduction - Kebijakan dan Strategi Indonesia
Harm Reduction - Kebijakan dan Strategi Indonesia
 
Dokumentasi Pelanggaran HAM di Kelompok Pengguna Narkoba Suntik
Dokumentasi Pelanggaran HAM di Kelompok Pengguna Narkoba SuntikDokumentasi Pelanggaran HAM di Kelompok Pengguna Narkoba Suntik
Dokumentasi Pelanggaran HAM di Kelompok Pengguna Narkoba Suntik
 
12 Concepts Anonymous
12 Concepts Anonymous12 Concepts Anonymous
12 Concepts Anonymous
 
Laporan Pertemuan Nasional Pengurangan Dampak Buruk Narkoba Suntik 2008
Laporan Pertemuan Nasional Pengurangan Dampak Buruk Narkoba Suntik 2008Laporan Pertemuan Nasional Pengurangan Dampak Buruk Narkoba Suntik 2008
Laporan Pertemuan Nasional Pengurangan Dampak Buruk Narkoba Suntik 2008
 
Upah, Harga, dan Laba
Upah, Harga, dan LabaUpah, Harga, dan Laba
Upah, Harga, dan Laba
 
Standar Biaya Umum Tahun Anggaran 2009
Standar Biaya Umum Tahun Anggaran 2009Standar Biaya Umum Tahun Anggaran 2009
Standar Biaya Umum Tahun Anggaran 2009
 
Protokol Opsional untuk Konvensi PBB Menentang Penyiksaan
Protokol Opsional  untuk Konvensi PBB Menentang  PenyiksaanProtokol Opsional  untuk Konvensi PBB Menentang  Penyiksaan
Protokol Opsional untuk Konvensi PBB Menentang Penyiksaan
 
Pedoman PelaksanaanProgram Terapi Rumatan Metadon di Lembaga Pemasyarakatan d...
Pedoman PelaksanaanProgram Terapi Rumatan Metadon di Lembaga Pemasyarakatan d...Pedoman PelaksanaanProgram Terapi Rumatan Metadon di Lembaga Pemasyarakatan d...
Pedoman PelaksanaanProgram Terapi Rumatan Metadon di Lembaga Pemasyarakatan d...
 
PENGATURAN KHUSUS PENYALURAN DAN PENYERAHAN BUPRENORFIN
PENGATURAN KHUSUS PENYALURAN DAN PENYERAHAN BUPRENORFINPENGATURAN KHUSUS PENYALURAN DAN PENYERAHAN BUPRENORFIN
PENGATURAN KHUSUS PENYALURAN DAN PENYERAHAN BUPRENORFIN
 

Último

PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 

Último (20)

PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 

Injecting Drug Use, HIV/AIDS Epidemic and Harm Reduction Strategies

  • 1. Injecting Drug Use, HIV/AIDS Epidemic and Harm Reduction Strategies Fabio Mesquita, MD, PhD Harm Reduction Adviser IHPCP - Indonesia Pertemuan Nasional HIV & AIDS Ke – 3 Surabaya – 2007
  • 2. TWO MAJOR EPIDEMICS AIDS DRUGS
  • 4.
  • 5.
  • 6.  
  • 7. Guiyang Kunming Mandalay Yangon Chiang Mai Bangkok Hanoi Vientian e Phnom Penh Ho Chi Minh City Songkhla MYANMAR LAOS CAMBODIA THAILAND VIETNAM CHINA Hong Kong MAJOR HEROIN TRAFFICKING ROUTES IN SE Asia Source: UNODC Regional Centre for East Asia and the Pacific Courtesy BBC World
  • 8. HIV/AIDS Hepatitis B, C and D Overdoses Hepatic chronic diseases Co-Morbidity with Mental Health Addiction Abscesses Endocarditic Syphilis, Malaria, HTLV, etc Tuberculosis/Other Respiratory diseases Car accident Occupational Accidents Violent deaths HEALTH CONSEQUENCES
  • 9. Adults and children estimated to be living with HIV as of end 2005 Total: 40.3 (36.7 – 45.3) million Western & Central Europe 720 000 [570 000 – 890 000] North Africa & Middle East 510 000 [230 000 – 1.4 million] Sub-Saharan Africa 25.8 million [23.8 – 28.9 million] Eastern Europe & Central Asia 1.6 million [990 000 – 2.3 million] South & South-East Asia 7.4 million [4.5 – 11.0 million] Oceania 74 000 [45 000 – 120 000] North America 1.2 million [650 000 – 1.8 million] Caribbean 300 000 [200 000 – 510 000] Latin America 1.8 million [1.4 – 2.4 million] East Asia 870 000 [440 000 – 1.4 million]
  • 10. Most countries have IDU ignited HIV Non IDU initiated IDU initiated
  • 11.
  • 12.
  • 13.
  • 14.
  • 15. CONDONS AVAILABLE FOR FREE DISTRIBUTION 800 MILLION FOR 2006 1 BILLION FOR 2007 PLUS REGULAR MARKET AND SOCIAL MARKET (DKT)
  • 16. TEST AND COUNSELING FIRST VCT OPEN IN 1989 TOTAL POPULATION EVER TESTED 28,1% - AUGUST 2004
  • 17.
  • 18. 0 20000 40000 60000 80000 100000 120000 140000 160000 180000 jan/97 abr/97 jul/97 out/97 jan/98 abr/98 jul/98 out/98 jan/99 abr/99 jul/99 out/99 jan/00 abr/00 jul/00 out/00 jan/01 abr/01 jul/01 out/01 jan/02 abr/02 jul/02 out/02 jan/03 abr/03 jul/03 out/03 jan/04 abr/04 jul/04 out/04 jan/05 abr/05 jul/05 out/05 170.000 * Dados preliminares Projected Number of patients receiving ARV therapy. Brazil, 1997 – 2005
  • 19.
  • 20. ARV availability in low and middle income countries, according to geographical region. June, 2005* Source: “Progress on Global Access to HIV Antiretroviral Therapy, June 2005 update, World Health Organization Region Number of people receiving ARVs Estimated need Coverage Sub-Saharan Africa 500,000 4,700,000 11% East, South and South-East Asia 155,000 1,100,000 14% North Africa and Middle East 4,000 75,000 5% Eastern Europe and Central Asia Central 20,000 160,000 13% Latin America and the Caribbean 290,000 465,000 62% Total 970,000 6,500,000 15% (Average) *Adults only, average figures
  • 21. AIDS Hospital Admissions in Public Health System in Post HAART Era. Brazil (1996-2001) Source: MOH, 2002
  • 22.
  • 23. AIDS incidence and mortality rates (by 100,000 inhabitants) Brazil, 1985-2003 Sources: Incidence - PN STD-AIDS/SVS/MH. Mortality – SIM/DASIS/SVS/MH 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 0 5 10 15 20 25 Mortality Incidence
  • 24. Distribution of PCP, Toxoplasmosis and Tuberculosis in Reported AIDS Cases to MOH (Brazil, 1981-2001) Source: MOH, 2002 HAART
  • 25. Estimate of HIV Infected Individuals (among 15 a 49 years old) by year 2000 Word Bank Projection (1992) Brazilian MOH Estimate (2000) 0 200 400 600 800 1000 1200 1400 Thousands 1,200,000 600,000 MOH, 2002  50%
  • 26. Dados de Casos de AIDS no Brasil Gráfico 1 – Casos de aids segundo ano de diagnóstico. Brasil, 1980-2003.                                                                                                                                                               Fonte: MS/SVS/PN DST e Aids/SINAN.  
  • 27. INDONESIAN RESPONSE FOR HIV/AIDS CRISIS AMONG AND FROM IDUS First AIDS case in Indonesia: 1987 First case in IDU: 1995 First Harm Reduction Project: 1999 Ongoing: NEP. Methadone, CST for IDUs
  • 28. Grafik 1: Jumlah Kasus AIDS di Indonesia 10 Tahun Terakhir Berdasarkan Tahun Pelaporan sd 31 Maret 2006 ----------------------------------------------------------------------------------------------------------- Figure 1 : Number of AIDS Cases in Indonesia in Last 10 Years up to March 31, 2006
  • 30.
  • 31. HIV PREVENTION AND CARE FOR IDUs After 25 years of the HIV/AIDS we’ve learned how to confront the epidemic among and from injecting drug users
  • 32.
  • 33.
  • 34. Evolution of Indonesian Response - NSP
  • 35.
  • 36.
  • 37.